During the past decade, Tufts Medical Center Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tufts Medical Center Research" are "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Tufts Medical Center Research" in a lesser frequency.

Most popular intervention types in "Tufts Medical Center Research" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials) and "Sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tufts Medical Center Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tufts Medical Center Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tufts Medical Center Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tufts Medical Center Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".